Unnaplast by Pharmaplast SAE Unnaplast®

Unnaplast by

Drug Labeling and Warnings

Unnaplast by is a Otc medication manufactured, distributed, or labeled by Pharmaplast SAE. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

UNNAPLAST- zinc oxide dressing 
Pharmaplast SAE

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Unnaplast®

Drug Facts

Active ingredient:

Zinc Oxide 10%

Purpose:

Skin Protectant

Uses:

Unnaplast® used in the treatment of Venous stasis ulcers, some selected eczematous eruptions, lymphatic edema, thrombophlebitis, minor fractures, sports injuries, sprains and strains and burns.

Warnings:

Reuse of the product increases risk of infection.
Dispose carefully in a manner preventing cross-contamination.
For external use only.
Do not make reverse turns while wrapping Unnaplast® bandage.
Do not use if you are hypersensitive to the product or any of its components.
Do not use on grossly macerated skin.
If condition worsens or does not improve within 7 days, consult a doctor.
Avoid contact with eyes.

Keep out of reach of children.

Directions:

1. Position the patient’s leg in a slightly flexed position.
2. Apply Unnaplast® in a circular motion from the foot to the knee. The wrap should be snug but not tight. To cover the area completely, be sure each turn overlaps the previous one by half the bandage’s width.
3. Continue wrapping the patient’s leg up to the knee, using firm even pressure. Mold the boot with your free hand as you apply the bandage to make it smooth.
4. Apply an elastic or cohesive bandage to secure dressing and maintain compression.

Inactive ingredients:

Carboxymethylcellulose
Glycerol
Purified water

Open weave cotton bandage with zinc oxide paste.

Pharmaplast

Made of open weave, light weight, finished selvage edges, cotton bandage impregnated with creamy zinc oxide paste.

Pharmaplast S.A.E.

Amria, free zone 23512,
Alexandria, Egypt
www.pharmaplast-online.com

Packaging

IMAGE

UNNAPLAST 
zinc oxide dressing
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 28691-1004
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC CATION - UNII:13S1S8SF37) ZINC CATION3 mg  in 1 cm2
Inactive Ingredients
Ingredient NameStrength
CARBOXYMETHYLCELLULOSE (UNII: 05JZI7B19X)  
GLYCERIN (UNII: PDC6A3C0OX)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 28691-1004-11 in 1 BOX02/17/202104/14/2023
16855 cm2 in 1 POUCH; Type 0: Not a Combination Product
2NDC: 28691-1004-21 in 1 BOX02/17/202104/14/2023
29140 cm2 in 1 POUCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34702/17/202104/14/2023
Labeler - Pharmaplast SAE (644773319)
Establishment
NameAddressID/FEIBusiness Operations
Pharmaplast SAE644773319manufacture(28691-1004)

Revised: 4/2023
 

Trademark Results [Unnaplast]

Mark Image

Registration | Serial
Company
Trademark
Application Date
UNNAPLAST
UNNAPLAST
98763899 not registered Live/Pending
Pharmaplast USA, LLC
2024-09-23
UNNAPLAST
UNNAPLAST
85973783 4523411 Live/Registered
Pharmaplast USA, LLC
2013-06-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.